Adenomyosis and uterine fibroids are distinct conditions with different underlying biology, different structural characteristics, and different treatment implications. They are also conditions whose symptoms overlap so significantly that they are frequently mistaken for each other — and sometimes both are present simultaneously, each contributing to a symptom picture that is more complex than either condition would produce alone.
Getting the distinction right matters because the treatment approaches are not interchangeable. Surgical removal of fibroids does not treat adenomyosis. Hormonal management that controls adenomyosis symptoms may have limited effect on fibroids producing mechanical pressure or bleeding from a different mechanism. A hysteroscopic procedure that addresses a submucosal fibroid may leave adenomyosis entirely untreated. When both conditions are present, a treatment plan that accounts for only one of them will produce incomplete results.
This page explains what each condition is, how they differ biologically and structurally, how their symptoms compare and where they overlap, how each is diagnosed, and what the treatment implications are when one or both are present. If you have been diagnosed with fibroids but your symptoms have not improved as expected with treatment, or if you have symptoms that fit both conditions, this page provides the clinical context that may have been missing from prior conversations.
Understanding the fundamental difference between adenomyosis and fibroids starts with understanding where each condition originates and what it does to uterine structure.
Uterine Fibroids — Discrete Growths Within or Around the Uterus
Uterine fibroids are discrete, well-defined, noncancerous growths that develop from the smooth muscle cells of the uterine wall. They are structurally separate from the normal uterine tissue surrounding them — they have defined borders, they can be identified individually on imaging, and they can in most cases be removed surgically as distinct structures. Fibroids can grow within the uterine wall (intramural), project into the uterine cavity (submucosal), grow outward from the uterine surface (subserosal), or develop on a stalk (pedunculated). Their clinical impact depends primarily on their location relative to the uterine lining and surrounding structures.
Adenomyosis — Uterine Lining Tissue Embedded in the Uterine Wall
Adenomyosis occurs when the glands and supporting tissue of the endometrium — the uterine lining that sheds during menstruation — grow into and become embedded within the muscular wall of the uterus (the myometrium). Unlike fibroids, adenomyosis does not form discrete, removable growths. It is a diffuse process in which endometrial tissue infiltrates the uterine muscle throughout the wall, causing the muscle to thicken, bleed with each menstrual cycle, and become progressively more reactive and painful over time. Adenomyosis cannot be surgically excised the way fibroids can — the affected tissue is distributed throughout the muscle wall rather than forming a structure that can be removed.
Adenomyoma — When Adenomyosis Forms a Focal Mass
In some cases, adenomyosis forms a localized, focal collection within the uterine wall called an adenomyoma. An adenomyoma can appear on ultrasound as a poorly defined thickening or mass within the uterine muscle — and it is precisely this appearance that creates diagnostic confusion with intramural fibroids. Fibroids typically appear as well-defined structures with clear borders on ultrasound, while adenomyomas tend to have less distinct margins and a more heterogeneous texture. The distinction is clinically important because an adenomyoma does not respond to surgical removal the same way a fibroid does — and its treatment requires different surgical planning.
The symptom profiles of adenomyosis and fibroids overlap substantially, which is the primary reason they are so often confused. The following comparisons highlight both the shared features and the distinguishing characteristics that help point toward one diagnosis versus the other — or both simultaneously.
Heavy Menstrual Bleeding — Both Conditions, Different Mechanisms
Both adenomyosis and fibroids cause heavy menstrual bleeding, but through different mechanisms. Submucosal and intramural fibroids increase the surface area and distortion of the uterine cavity, impairing the uterus’s ability to contract and control blood loss. Adenomyosis causes the uterine muscle to become engorged with blood and inflammatory mediators each cycle, producing a heavy, prolonged bleed that is driven by the widespread infiltration of the muscle rather than by a discrete structural growth. Distinguishing between fibroid-related and adenomyosis-related heavy bleeding is relevant to treatment planning because each responds to different interventions.
Pelvic Pain — Similar Symptoms, Different Character
Both conditions cause pelvic pain, but the character of adenomyosis pain is typically more diffuse, more deeply aching, and more consistently linked to the menstrual cycle than fibroid-related pain. Adenomyosis frequently produces severe dysmenorrhea — menstrual cramping that is significantly worse than typical period pain, often beginning before the period starts and persisting throughout. Fibroid-related pain tends to be more associated with the mechanical effects of fibroid mass — pressure, heaviness, and localized discomfort — rather than the diffuse, cyclical, cramping quality of adenomyosis pain. When both conditions are present, severe cramping alongside pelvic pressure and heavy bleeding often indicates concurrent adenomyosis and fibroids.
Uterine Enlargement — Common to Both, Different in Character
Both adenomyosis and multiple or large fibroids can produce a significantly enlarged uterus. The difference is in the texture and distribution of that enlargement. A fibroid uterus typically has an irregular, lumpy contour produced by discrete fibroid growths of varying sizes. An adenomyotic uterus tends to be more uniformly enlarged and softer in texture, with a globular, symmetric appearance on ultrasound rather than the asymmetric, nodular contour of a heavily fibroid-laden uterus. An experienced examiner can often distinguish between the two on pelvic examination, but ultrasound and sometimes MRI are required for a definitive assessment.
Symptoms More Characteristic of Adenomyosis
Severe dysmenorrhea that begins before the onset of flow and persists throughout the cycle. Pain during intercourse with a deep, aching quality. Progressively worsening menstrual pain over years. A soft, uniformly enlarged, tender uterus on examination. Heavy bleeding accompanied by significant cramping that is poorly responsive to NSAIDs. These features, particularly in combination, are more suggestive of adenomyosis than fibroids — though the overlap is significant and imaging is required to clarify the diagnosis.
Symptoms More Characteristic of Fibroids
Pelvic pressure, fullness, or heaviness in the lower abdomen. Bladder urgency or urinary frequency. Lower back pain radiating into the thighs. Visible or palpable abdominal enlargement with an irregular or asymmetric contour. Heavy bleeding without severe cramping. These features are more characteristic of fibroids than adenomyosis — particularly when pressure and bulk symptoms predominate over pain. Again, the overlap is real, and both conditions can produce a similar overall symptom burden in any given patient.
When Both Are Present — A More Complex Clinical Picture
Adenomyosis and fibroids coexist in a significant proportion of women who have one or the other diagnosis. When both are present, the symptom burden is typically greater than either condition would produce alone. Heavy bleeding, severe pain, significant uterine enlargement, and multiple pressure symptoms occurring together in a woman in her late 30s or 40s should prompt evaluation for both conditions simultaneously. A treatment plan that addresses only the fibroids while leaving adenomyosis untreated will produce incomplete results — and an explanation for why symptom improvement after fibroid surgery was less than expected.
Accurate diagnosis of adenomyosis versus fibroids — or both — requires imaging and a thorough clinical evaluation. The diagnostic workup at Lapeer Women’s Health is led by Dr. Ramona D. Andrei, MD, PhD, FACOG, with an emphasis on getting the diagnosis right before building any treatment plan.
Pelvic Ultrasound — First-Line Imaging for Both
Pelvic ultrasound is the primary imaging tool for evaluating both conditions. Fibroids appear as well-defined masses with discrete borders. Adenomyosis produces characteristic changes in the uterine wall — asymmetric thickening, heterogeneous texture, cystic spaces within the muscle, and a poorly defined endometrial-myometrial junction — that an experienced sonographer can identify with reasonable accuracy. Transvaginal ultrasound provides higher resolution imaging of the uterine wall and is an important part of the evaluation when adenomyosis is suspected.
MRI — When Greater Diagnostic Precision Is Needed
MRI provides superior soft tissue contrast compared to ultrasound and is the most accurate noninvasive imaging tool for distinguishing adenomyosis from intramural fibroids, characterizing the extent of adenomyosis within the uterine wall, and identifying concurrent conditions. It is particularly valuable when ultrasound findings are ambiguous, when surgical planning requires precise anatomical characterization, or when prior treatment has not produced expected results and a more detailed evaluation is warranted.
Clinical History — An Essential Diagnostic Tool
The character, pattern, and progression of symptoms over time remain among the most valuable diagnostic inputs. A carefully taken clinical history — including the specific quality of pain, its relationship to the menstrual cycle, how symptoms have evolved over years, and what treatments have and have not helped — adds essential context to imaging findings and often resolves diagnostic ambiguity that imaging alone cannot definitively clarify.
The treatment approaches for adenomyosis and fibroids overlap in some areas but diverge in others. Understanding those divergences is essential to building a plan that actually addresses what is driving your symptoms.
Hormonal medications that suppress estrogen — including GnRH agonists, GnRH antagonists, and progestin-dominant therapies — are effective for managing symptoms of both adenomyosis and fibroids because both conditions are estrogen-responsive. A hormonal IUD can significantly reduce bleeding and pain from adenomyosis and is one of the most consistently effective medical options for adenomyosis specifically. Combined oral contraceptives and progestin therapy are also used for both conditions. When both conditions coexist, medical management may address symptoms from both simultaneously, making it a particularly valuable approach for women who are not yet ready for surgical intervention.
Myomectomy removes discrete fibroids while leaving the uterus intact. It is highly effective for the symptoms produced by fibroids — particularly heavy bleeding from submucosal fibroids and pressure symptoms from subserosal or large intramural fibroids. However, myomectomy does not treat adenomyosis. If adenomyosis is present alongside fibroids and is not addressed in the treatment plan, symptom improvement after myomectomy may be incomplete. This is one of the most important reasons that an accurate preoperative diagnosis of both conditions is essential before proceeding with surgery.
Hysterectomy is the only surgical treatment that definitively resolves both fibroids and adenomyosis simultaneously — because both conditions exist within the uterine tissue that is removed. For women with both conditions who have completed childbearing and whose symptoms have not been adequately controlled by medical management or uterus-preserving surgery, minimally invasive hysterectomy addresses both conditions in a single procedure. Dr. Andrei performs laparoscopic and robotic-assisted hysterectomy with a consistent emphasis on minimally invasive approaches and reduced recovery time.
One of the most common clinical scenarios that leads women to seek a second gynecologic opinion is the experience of undergoing treatment for fibroids — whether medical or surgical — and finding that their symptoms have improved less than expected or have not improved at all. In many of these cases, the missing piece is adenomyosis that was not identified or not adequately factored into the treatment plan.
If your treatment history includes fibroid management that has not resolved your symptoms, or if your symptom picture includes both the pressure and bulk symptoms typical of fibroids and the severe cyclical pain and cramping more characteristic of adenomyosis, a careful re-evaluation that specifically looks for both conditions is worth pursuing.
Dr. Ramona D. Andrei and the team at Lapeer Women’s Health provide that level of evaluation — at both our Lapeer and Rochester Hills offices, without a referral required.
Adenomyosis vs. Fibroids
An evaluation that specifically considers both adenomyosis and fibroids — and their interaction — is the starting point for a treatment plan that actually works. Our team at Lapeer Women’s Health is here to provide that evaluation at both our Lapeer and Rochester Hills offices. No referral required.
Schedule a Gynecologic VisitThe information on this page is intended for educational purposes only and does not constitute medical advice. Individual symptoms, diagnoses, and treatment options vary significantly. Reading this content does not establish a physician-patient relationship with Dr. Ramona D. Andrei or Lapeer Women’s Health. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately. Please consult a qualified healthcare provider for advice specific to your situation. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.